Table 2

Treatment characteristics and outcome in vascular complications following IVIG treatment

Patient (ref)IVIG doseNumber of treatmentsDay of the event/eventOutcome
A Patients with MI
 Patient 1(14) 500 g/d,3 days81Recovery
 Patient 2(12) 400 g/d, 5 days13Death
 Patient 3(12) 400 g/d, 5 days16Death
 Patient 4(17) 1 g/d, 2 days11Death
 Patient 5(16) NDNDNDDeath
 Patient 6* 650 g/d, 3 days110Recovery
 Patient 7* 1000 g/d, 3 days157Recovery
 Patient 8* 400 g/d, 5 days11Recovery
 Patient 9* 400 g/d, 5 days54Recovery
B Patients with IVIG related thrombotic events other than MI
 Patient 10(13) 400 g/d, 5 days16 /CVADeath
 Patient 11(12) 400 g/d, 5 days14 /CVADeath
 Patient 12(12) 400 g/d, 5 days15 /CVAND
 Patient 13(15) ND22 /PEDeath
 Patient 14(15) 400 g/d, 5 days212 /Spinal eventDeath
 Patient 15(18) 400 g/d, 5 days115 /CVARecovery
  • ND: not determined; CVA: cerebrovascular accident; PE: pulmonary embolism.